Mark R Tanner

9PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton

|Mar 06, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.

Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang

|Jul 18, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.

Oren Pasvolsky, Denái R Milton, Adeel Masood

|Jun 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.

Oren Pasvolsky, Curtis Marcoux, Denái R Milton

|Feb 18, 2018
Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.

Mark R Tanner, Michael W Pennington, Brayden H Chamberlain

Pageof 2

Frequent Collaborators

8 joint publications

Muzaffar H Qazilbash

7 joint publications

Yago Nieto

7 joint publications

Robert Z Orlowski

6 joint publications

Oren Pasvolsky